Akademik Veri Yönetim Sistemi
INTERNATIONAL JOURNAL OF DERMATOLOGY, cilt.43, sa.2, ss.151-154, 2004 (SCI-Expanded)
Background Systemic antibiotics currently used in the treatment of rosacea are sometimes associated with uncomfortable side-effects. Therefore, a need for an effective agent with few side-effects and good patient compliance exists. Azithromycin, a macrolide antibiotic with prolonged mode of action, has recently been found to be an effective alternative in the treatment of inflammatory acne. We planned a study to evaluate the efficacy and safety of azithromycin in rosacea.